Home > Insider Trading > Filing (0000819050-21-000125)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
819050	Brickell Biotech Inc.	BBI	Biological Products, (No Disgnostic Substances) (2836)	930948554

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1008105	L Reginald Hardy	C/O Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder CO 80301	Chairman Of The Board	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-07-23	100,000	$0.66	348,411	No	4	P	Direct
Common Stock	Acquisiton	2021-07-26	100,000	$0.67	448,411	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,261	Indirect	By Spouse
Common Stock	21,826	Indirect	By Spouse (spouse jointly owns with other Individual)
Common Stock	17,260	Indirect	By Spouse as Trustee
Common Stock	266,447	Indirect	By Self as General Partner
Common Stock	17,260	Indirect	By Self as Trustee

Footnotes

Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.66 to $0.6720 per share, resulting in a weighted average purchase price of $0.6623. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.671 to $0.678 per share, resulting in a weighted average purchase price of $0.6742. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.